0001104659-20-138669.txt : 20201222
0001104659-20-138669.hdr.sgml : 20201222
20201222174901
ACCESSION NUMBER: 0001104659-20-138669
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUYER DAVID R
CENTRAL INDEX KEY: 0001277476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 201409153
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm2039210-1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-18
0
0001410939
IVERIC bio, Inc.
ISEE
0001277476
GUYER DAVID R
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK
NY
10001
1
1
0
0
Executive Chairman
Stock Option (Right to Buy)
7.50
2020-12-18
4
A
0
205150
0
A
2030-12-17
Common Stock
205150
205150
D
Restricted Stock Units
2020-12-18
4
A
0
102630
0
A
Common Stock
102630
102630
D
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in equal monthly installments through the fourth anniversary of the grant date, and (3) such stock option shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change in control of the Registrant.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Todd Anderman, as Attorney-in-Fact for David R. Guyer
2020-12-22